Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 25 Apr 23 EFFECT Notice of effectiveness
- 24 Apr 23 424B5 Prospectus supplement for primary offering
-
29 Mar 23 F-3 Shelf registration (foreign)
PRQR similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our reports dated March 29, 2023, with respect to the consolidated financial statements of ProQR Therapeutics N.V., and the effectiveness of internal control over financial reporting, incorporated herein by reference, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG Accountants N.V. |
Amstelveen, The Netherlands
March 29, 2023